Career history of Sarina Chohan
Former positions of Sarina Chohan
Companies | Position | Start | End |
---|---|---|---|
Lipomics Technologies, Inc.
Lipomics Technologies, Inc. BiotechnologyHealth Technology Lipomics is uniquely positioned as a leader in personalized medicine for metabolic disorders. Developing diagnostics for metabolic diseases. Its research and development efforts apply proprietary techniques in lipid profiling and data interpretation to identify clinically relevant biomarkers and validate their potential for diagnostic tests. Working with strategic partners, Lipomics Technologies is advancing its goal to develop clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation. Its service unit provides biomarker discovery and biological consultation services for advancing drug development with their pharmaceutical partners. The company generates high-quality quantitative profiles of lipid metabolites that are central to metabolic diseases. These metabolites include eicosanoids, acylcarnitines, sterols, bile acids and structural and energetic lipids. In addition to quantitative metabolite profiling, Lipomics provides bioinformatic analysis and biological interpretation services. | Sales & Marketing | 2001-12-31 | 2009-09-10 |
HP INC. | Corporate Officer/Principal | - | - |
Training of Sarina Chohan
University of Greenwich | Masters Business Admin |
UC Davis School of Medicine | Undergraduate Degree |
Statistics
International
United States | 3 |
United Kingdom | 2 |
Mauritius | 2 |
Operational
Sales & Marketing | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
HP INC. | Electronic Technology |
Private companies | 1 |
---|---|
Lipomics Technologies, Inc.
Lipomics Technologies, Inc. BiotechnologyHealth Technology Lipomics is uniquely positioned as a leader in personalized medicine for metabolic disorders. Developing diagnostics for metabolic diseases. Its research and development efforts apply proprietary techniques in lipid profiling and data interpretation to identify clinically relevant biomarkers and validate their potential for diagnostic tests. Working with strategic partners, Lipomics Technologies is advancing its goal to develop clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation. Its service unit provides biomarker discovery and biological consultation services for advancing drug development with their pharmaceutical partners. The company generates high-quality quantitative profiles of lipid metabolites that are central to metabolic diseases. These metabolites include eicosanoids, acylcarnitines, sterols, bile acids and structural and energetic lipids. In addition to quantitative metabolite profiling, Lipomics provides bioinformatic analysis and biological interpretation services. | Health Technology |
- Stock Market
- Insiders
- Sarina Chohan
- Experience